#prostatecancer نتائج البحث
There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm
Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.
Brilliant panel at #UromigosLive w an array of #ProstateCancer superstars, including my @cityofhope boss @TDorffOnc, @huntsmancancer program leader @neerajaiims, @ChrisSweens1, Morris & @charlesryanmd. @brian_rini doing an exceptional job navigating a complex discussion.…
The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…
The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…
Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻
Free tonight? In the Los Angeles area? Please come join our @cityofhope GU team leader @TDorffOnc for a terrific @OncLiveSOSS in Arcadia, CA covering NMIBC (@WesleyYipMD), #kidneycancer (@charlesbnguyen) & #prostatecancer (@arafflemd). Monday 11/17 at 5:30 pm - hope to see you…
If you, or a loved one, has been diagnosed with #ProstateCancer, our free One-to-One Peer Support service is like having a friend who gets it at the end of the phone. ➡️ Find out more: bit.ly/4id1x2F #MensHealth l #Support
🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025
New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer
AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ #NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR) ascopubs.org/doi/10.1200/JC… The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…
Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! #Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda…
Meet #CamPROBE from @medovate a game-changer in prostate biopsies🔬 ✓ Lower infection risk ✓ Less invasive ✓ Simple to use ✓ Cost-effective Experience safer, more comfortable patient outcomes with our innovative transperineal biopsy device #ProstateDiagnostics #prostatecancer
1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum! Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. bit.ly/4nzJRyV Thanks to @LouiseKostos Heidi Fettke @PeterMacCC
#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
🚀 LUNAR phase II trial RCT of pts w/ oligorecurent hormone-sensitive #ProstateCancer 🖊️ @JCO_ASCO 🎯 Patients (n=92) randomized 1:1 to SBRT alone or ¹⁷⁷Lu-PNT2002 followed by SBRT ⭐️PFS doubled: 17.6 mo vs 7.4 months (HR 0.37, P<.0001) 📉 >50% PSA drops in 52% vs 31% 🧲…
Editor @msstaceyerin revisits a popular topic to see whether #regenerativemedicine is advancing #ProstateCancer research. Sprouting a ’stache is fun… but sprouting hope is even better. Comb through the full story signalsblog.ca/right-turn-bey… #Movember #MensHealth #CancerResearch
Not a single #Thanksgiving has gone by over the past decade when I haven’t been grateful for having my boss/ally/friend @TDorffOnc at @cityofhope. Beyond the incredible strides she has made in #immunotherapy for #prostatecancer, she has led our growing group with integrity,…
In the latest episode of On the Edge of Breakthrough, @montypal and @TDorffOnc discuss her pioneering work in immunotherapy for prostate cancer, the importance of collaborative team-science, and so much more! Watch and subscribe: bit.ly/3M0bK6l
Visit Oncotarget's Special Collection on Prostate Cancer: oncotarget.com/collections/pr… #prostatecancer #cancerresearch #cancer #openaccess #publishing
#prostatecancer Coping with #Cancer amazon.com/dp/B09P7LZJTQ/
🔗 AFU recommendations for #prostatecancer 2025 (summary of changes): doi.org/10.1016/j.fjur… 🔗 PRIME in @JAMA_current: doi.org/10.1001/jama.2… #UroSoMe #prostateMRI #EMUC25
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? @CaPsurvivorship shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedX #ProstateCancer #Movember ow.ly/ap8W50XyGu2
Looking to speak to black men about #prostatecancer awareness and screening in the UK - for a sensitive Men's Health magazine piece. Can be anon. Please email [email protected] #journorequest #blacktwitter
Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model nature.com/articles/s4139… In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…
New therapeutic strategies show promise against a hard-to-treat prostate cancer. ow.ly/r3NC50XyCn3 #ProstateCancer #CancerResearch #Oncology #CancerAwareness #CancerTreatment
It's absolutely right the the UK National Screening Committee get hold of prostate cancer screening & implement it ASAP. The SoS for Health @wesstreeting @DHSCgovuk @NHSuk need to push hard for this. #prostatecancer
📢 There’s still time to sign up! Men across Greater Manchester are invited to our online prostate cancer focus group. 🗓 Fri 28 Nov 2025 🕚 11:30am 💻 Microsoft Teams 👉 Call 0161 253 6300 or email [email protected] #prostatecancer
📝Access mCRPC treatment guidance in seconds with @ONCOassist This tool presents efficacy data from recent trials of novel treatments for patients with mCRPC. #mCRPC #ProstateCancer #OncologyTools #CancerCare #ClinicalOncology #DigitalHealth #OncologyApp…
Prostate cancer hits thousands of men in the UK every year - and most cases caught early are treatable. This design is a reminder: lads, stop ignoring the check-ups. Awareness saves lives. 💙 #ProstateCancer #MensHealth #BlueRibbon
A new study suggests many men with prostate cancer may not need long-term hormone therapy. Researchers found most ADT benefits happen in the first 9–12 months. Smarter treatment, fewer side effects. #ProstateCancer #CancerResearch #TCSC #Oncology #Cancer newsroom.ucla.edu/releases/long-…
👨⚕️ Prostate cancer is the most common cancer in men. Spotify: bit.ly/41vadZU Apple: bit.ly/4h9OsF1 Amazon: bit.ly/4i5B99Y YouTube: bit.ly/4ktGnhm #ProstateCancer #Movember #MensHealth #ProstateCancerAwarenessMonth #CancerPodcast
youtube.com
YouTube
Episode 11: Standing up to prostate cancer
C'mon, chop, chop! Get #ProstateCancer screening up & running! We MUST commence working towards making vast reductions in the number of men diagnosed 'incurable', then the same for 'Aggressive PCa'. The vision must be 80% are treated through Focal Therapy, by 2036.
Screening smartly catches aggressive cancers early when they're highly curable & with less side effects, while avoiding unnecessary tests, biopsies and anxiety for those at low risk says @marclaniado dailymail.co.uk/news/article-1…
3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer
⚕ A quick #PSA blood test could help catch prostate cancer early. Men 50+: make PSA screening a yearly habit. 📍PSA Test bhx.one/PBc6Mh 📍Urology Center bhx.one/rvw4AR 📍Packages bhx.one/RZPaKg #ProstateCancer #MensHealth #EarlyDetection #Bumrungrad
🧔♂️ November is #Movember – raising awareness for #MensHealth & #ProstateCancer. At #OPTIMA, we're using #AI & #RealWorldData to support better, personalised care. Early detection saves lives. Let's talk, share, and support innovation in cancer care. #AIforCancer #CancerCare
🚨23 years of PSA screening in @NEJM 🚨 👉ERSPC RCT of >162k patients 📅Median 23 year f/u PSA screening lead to... 📉 #prostatecancer mortality by 13% ✅1 death prevented for every 456 men invited for screening or 12 diagnosed w/ PCa 📉Risk of advanced PCa by 34% ⭐️Benefit…
🚨ENZARAD at #ESMO25 presented by @DrPaulNguyen No improvement in MFS or OS with the addition of enzalutamide to high dose radiotherapy + 2y ADT in high risk #prostatecancer Possible benefit in cN1 pts or pts treated with pelvic RT.
Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.
The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…
🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025
John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪 The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way. He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙
Five years on, we’re celebrating the life and legacy of our incredible ambassador and friend, #RayClemence 💙 A true @England legend, Ray faced #ProstateCancer for more than 15 years with remarkable courage and compassion, all while tirelessly supporting our work.
Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! #Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda…
European Study of Prostate Cancer Screening — 23-Year Follow-up nejm.org/doi/full/10.10… The 23-year follow-up of the European Randomized Study of Screening for #ProstateCancer (ERSPC) confirms that PSA-based screening yields a sustained reduction in prostate cancer mortality.…
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced #ProstateCancer link.springer.com/article/10.100… This paper discusses the emerging role of PSMA-PET/CT and whole-body MRI (WB-MRI) in prostate cancer, emphasizing their superior accuracy over conventional CT and bone…
Metformin Active Surveillance Trial in Low-Risk Prostate Cancer ascopubs.org/doi/abs/10.120… The phase III Metformin Active Surveillance Trial (MAST) evaluated whether metformin could delay disease progression in men with low-risk, localized #ProstateCancer managed with active…
New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…
There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm
🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe
Simulation-free radiotherapy on the MR-linac in prostate cancer academic.oup.com/bjr/article/98… This study examined whether diagnostic MRI (dMRI) scans could replace dedicated simulation imaging for planning MRI-guided adaptive radiotherapy (MRIgART) in #ProstateCancer . Reviewing…
#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
PRESTO Presented at #ESMO25 A phase III open-label study of combined androgen blockade in patients with high-risk biochemically relapsed #ProstateCancer cslide.ctimeetingtech.com/esmo2025/atten… PRESTO evaluated whether adding apalutamide (APA) with or without abiraterone💊 acetate plus…
The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…
STOPCAP at #ESMO26 Benefit of #radiotherapy in de novo M1 #prostatecancer on OS & PFS. Restricted to <5 bone or low volume mets on conventional imaging. No interaction with other patient/tumor characteristics.
Textbook images of prostate NB with therapy-related changes #gupath ☢️ Poorly-formed glands/single cells w/vacuolization & prominent nucleoli = #ProstateCancer ☢️ Multi-layered glands w/eosinophilic cytoplasm, variable nuclear size & fine peri-glandular fibrosis = Benign
Something went wrong.
Something went wrong.
United States Trends
- 1. Thanksgiving 2.08M posts
- 2. Chiefs 65.9K posts
- 3. Mahomes 23.2K posts
- 4. George Pickens 9,430 posts
- 5. Post Malone 4,577 posts
- 6. Tony Romo 2,394 posts
- 7. Turpin 1,664 posts
- 8. Sarah Beckstrom 86.7K posts
- 9. #KCvsDAL 6,149 posts
- 10. McDuffie 4,982 posts
- 11. Lions 99.7K posts
- 12. Packers 73.3K posts
- 13. Rashee Rice 3,597 posts
- 14. Kelce 13.7K posts
- 15. Hollywood Brown N/A
- 16. Dan Campbell 8,297 posts
- 17. Clowney N/A
- 18. Andy Reid 1,454 posts
- 19. Dak Prescott 4,850 posts
- 20. Spags 1,273 posts